Log in

LON:SBS - Source Bioscience Share Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume458,233 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Source BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
Phone+44-115-9739012

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter.


Source Bioscience (LON:SBS) Frequently Asked Questions

What is Source Bioscience's stock symbol?

Source Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "SBS."

Has Source Bioscience been receiving favorable news coverage?

Headlines about SBS stock have trended somewhat positive this week, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Source Bioscience earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Source Bioscience.

What other stocks do shareholders of Source Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Source Bioscience investors own include Anglo American (AAL), Hastings Group (HSTG), Renishaw (RSW), Spirent Communications (SPT), Rotork (ROR), Hiscox (HSX), SkyePharma (SKP), Anglo American (NGLOY), Discoverie Group (DSCV) and Diamondcorp (DCP).

How do I buy shares of Source Bioscience?

Shares of SBS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How can I contact Source Bioscience?

Source Bioscience's mailing address is 1 Orchard Place Nottingham Business Park, NOTTINGHAM, NG8 6PX, United Kingdom. The company can be reached via phone at +44-115-9739012.


MarketBeat Community Rating for Source Bioscience (LON SBS)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  172
MarketBeat's community ratings are surveys of what our community members think about Source Bioscience and other stocks. Vote "Outperform" if you believe SBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel